64 related articles for article (PubMed ID: 38581546)
1. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
Luo L; Jiao Y; Li Y; Yang P; Gao J; Huang S; Huang W; Wang J; Dong F; Ke X; Zou D; Gao C; Jing H
Ann Hematol; 2024 Jun; 103(6):2073-2087. PubMed ID: 38581546
[TBL] [Abstract][Full Text] [Related]
2. Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.
Yu J; Luo Y; Wang L; Wang T; Ye M; Chen J; Ni X; Chen L; Gao L; Yang J
Cancer Med; 2024 May; 13(10):e7310. PubMed ID: 38785213
[TBL] [Abstract][Full Text] [Related]
3. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
Aygüneş U; Karagün BŞ; Şaşmaz I; Antmen AB
Clin Transplant; 2024 May; 38(5):e15366. PubMed ID: 38775798
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma.
Zhao J; Guo X; Zheng M; Su L
Open Life Sci; 2024; 19(1):20220771. PubMed ID: 38840889
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.
Klyuchnikov E; Bacher U; Woo Ahn K; Carreras J; Kröger NM; Hari PN; Ku GH; Ayala E; Chen AI; Chen YB; Cohen JB; Freytes CO; Gale RP; Kamble RT; Kharfan-Dabaja MA; Lazarus HM; Martino R; Mussetti A; Savani BN; Schouten HC; Usmani SZ; Wiernik PH; Wirk B; Smith SM; Sureda A; Hamadani M
Bone Marrow Transplant; 2016 Jan; 51(1):58-66. PubMed ID: 26437062
[TBL] [Abstract][Full Text] [Related]
7. Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI.
Xu L; Weng J; Huang X; Zeng C; Chen S; Geng S; Yang L; Wu S; Huang S; Du X; Li Y
Oncotarget; 2016 Jul; 7(28):42943-42952. PubMed ID: 27356746
[TBL] [Abstract][Full Text] [Related]
8. Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
Kirchberg J; Fischer L; Born P; Brunner F; Morgner C; Fürst D; Heyn S; Bach E; Brueckner M; Jentzsch M; Wang SY; Böttcher S; Franke GN; Schrezenmeier H; Platzbecker U; Merz M; Vučinić V
Clin Lymphoma Myeloma Leuk; 2024 May; ():. PubMed ID: 38821728
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
Salgado M; Gálvez C; Nijhuis M; Kwon M; Cardozo-Ojeda EF; Badiola J; Gorman MJ; Huyveneers LEP; Urrea V; Bandera A; Jensen BO; Vandekerckhove L; Jurado M; Raj K; Schulze Zur Wiesch J; Bailén R; Eberhard JM; Nabergoj M; Hütter G; Saldaña-Moreno R; Oldford S; Barrett L; Ramirez MLM; Garba S; Gupta RK; Revollo B; Ferra-Coll C; Kuball J; Alter G; Sáez-Cirión A; Diez-Martin JL; Duke ER; Schiffer JT; Wensing A; Martinez-Picado J;
Lancet HIV; 2024 Jun; 11(6):e389-e405. PubMed ID: 38816141
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus infection among pediatric patients with cancer and in pediatric recipients of hematopoietic stem cell: A multicenter nationwide study.
Zając-Spychała O; Pieczonka A; Wachowiak J; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Kazanowska B; Wróbel G; Chybicka A; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Irga-Jaworska N; Bień E; Drożyńska E; Stolpa W; Sobol-Milejska G; Pierlejewski F; Młynarski W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Gamrot-Pyka Z; Woszczyk M; Urbanek-Dądela A; Karolczyk G; Płonowski M; Krawczuk-Rybak M; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Styczyński J
J Med Virol; 2020 Dec; 92(12):3187-3193. PubMed ID: 32162698
[TBL] [Abstract][Full Text] [Related]
11. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation.
Major-Monfried H; Hosszu K; McAvoy DP; Vallone A; Shukla N; Gillio A; Spitzer B; Kung AL; Cancio M; Curran K; Scaradavou A; Oved JH; O'Reilly RJ; Boelens JJ; Harris AC
Cytotherapy; 2024 May; 26(5):466-471. PubMed ID: 38430078
[TBL] [Abstract][Full Text] [Related]
12. [Role and progress of allogeneic hematopoietic stem cell transplantation in the treatment of refractory/relapsed diffuse large B-cell lymphoma].
Cao LQ; Mo XD
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):308-312. PubMed ID: 38716606
[TBL] [Abstract][Full Text] [Related]
13. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia.
Kurosawa S; Fukuda T; Ichinohe T; Hashii Y; Kanda J; Goto H; Kato K; Yoshimitsu M; Ishimaru F; Sato A; Onizuka M; Matsuo K; Ito Y; Yanagisawa A; Ohbiki M; Tabuch K; Atsuta Y; Arai Y;
Cytotherapy; 2024 May; ():. PubMed ID: 38804991
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of air-leak syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients.
Zhao W; Wang R; Chen M
Pediatr Blood Cancer; 2024 Jul; 71(7):e31008. PubMed ID: 38676303
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic Next-generation Sequencing May be a Tool for Timely Diagnosis of Seronegative and Primary Toxoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.
Lv Q; Cao Y; Wang J; Meng L; Wang G
Pediatr Infect Dis J; 2024 Feb; 43(2):155-159. PubMed ID: 38190489
[TBL] [Abstract][Full Text] [Related]
16. Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective.
Navas Huerga R; Salcedo de Diego I; de Miguel Jiménez C; Muñoz Martínez C; Kwon M; Pedraza García N; Calbacho M; Royuela Vicente A; Serrano Gallardo P
Eur J Oncol Nurs; 2024 Jun; 70():102584. PubMed ID: 38631123
[TBL] [Abstract][Full Text] [Related]
17. When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.
Lamble A; Phelan R; Burke M
J Clin Med; 2017 Jul; 6(7):. PubMed ID: 28686179
[TBL] [Abstract][Full Text] [Related]
18. A Rare Case of Early T-Precursor Lymphoblastic Lymphoma (ETP-LBL) in a Child With Nijmegen Breakage Syndrome.
R Brannock K; Kahwash SB
Pediatr Dev Pathol; 2024 May; ():10935266241255277. PubMed ID: 38794943
[TBL] [Abstract][Full Text] [Related]
19. Turkish Hematologists' Preferences for Relative Donor Selection: Results of a Multicenter Survey.
Gülkan Özkan S; Kimiaei A; Kaya AH; Pepeler MS; Özkan HA; Arat M
Turk J Haematol; 2024 May; ():. PubMed ID: 38801065
[TBL] [Abstract][Full Text] [Related]
20. The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
Oltolini C; Travi G; Mikulska M
Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38835096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
